There's a big difference between being in the right place at the right time and executing well on a business opportunity. After a few years of stellar growth during the pandemic, it suddenly looks like Doximity (NYSE: DOCS) -- like so many other pandemic-era growth stories -- falls in the former category.

I don't say this simply because its shares plunged more than 20% after recent earnings, putting it in camp with quite a few other small stocks that haven't held up so well during this summer's earnings season. Rather, it looks like management was really out of touch when touting their ambitious growth plans.

Here's what investors need to know.

Continue reading

Source Fool.com